Emerging immune targets for the treatment of multiple myeloma

Sohail, A; Mushtaq, A; Iftikhar, A; Warraich, Z; Kurtin, SE; Tenneti, P; McBride, A; Anwer, F

Anwer, F (reprint author), Univ Arizona, Dept Med, Div Hematol Oncol, Tucson, AZ 85724 USA.

IMMUNOTHERAPY, 2018; 10 (4): 265

Abstract

We reviewed emerging immune strategies for multiple myeloma (MM) therapy excluding US FDA approved drugs. In relapsed refractory MM, isatuximab (anti-......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索